ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New RNA combo tackles tough liver cancer in early trial
Disease control OngoingThis early-phase study tests a new RNA-based drug (MTL-CEBPA) combined with two standard immunotherapy drugs (atezolizumab and bevacizumab) in people with advanced liver cancer who have not had prior treatment. The main goals are to find the safest dose and see how the tumors res…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated May 26, 2026 09:37 UTC
-
New immunotherapy cocktail shows promise for untreatable liver cancer
Disease control OngoingThis study tests a combination of two immune-boosting drugs (durvalumab and tremelimumab) as the first treatment for people with advanced liver cancer that cannot be removed by surgery. About 111 participants will receive the drugs to see how safe they are and whether they shrink…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
Engineered immune cells take on Hard-to-Treat liver cancer
Disease control TerminatedThis early-stage trial tests a new treatment for people with advanced liver cancer that has not responded to standard therapies. The treatment uses the patient's own immune cells, modified in a lab to recognize and attack cancer cells carrying a specific protein called GPC3. The …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New cell therapy trial targets tough liver cancer
Disease control OngoingThis early-phase study tests a new cell treatment called CT0180 in people with advanced liver cancer that has not responded to other therapies. The main goals are to check safety, find the best dose, and see how the body handles the treatment. About 21 adults aged 18 to 75 will r…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC